Myriad RBM Revenue and Competitors

Austin, TX USA

Location

$25M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Myriad RBM's estimated annual revenue is currently $41.9M per year.(i)
  • Myriad RBM's estimated revenue per employee is $193,750
  • Myriad RBM's total funding is $25M.

Employee Data

  • Myriad RBM has 216 Employees.(i)
  • Myriad RBM grew their employee count by -41% last year.

Myriad RBM's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$2.5M1645%N/AN/A
#2
$13.8M89-7%N/AN/A
#3
$18.6M1203%$1.8MN/A
#4
$0.9M6-40%N/AN/A
#5
$4.2M270%N/AN/A
#6
$3.4M2247%N/AN/A
#7
$9.6M6229%N/AN/A
#8
$0.9M620%N/AN/A
#9
$1.7M1110%N/AN/A
#10
$15.2M98-8%N/AN/A
Add Company

What Is Myriad RBM?

Myriad RBM, Inc. is the world's leading multiplexed immunoassay testing laboratory, providing comprehensive protein biomarker services based on its Multi-Analyte Profiling (MAP) platform. This platform provides pre-clinical and clinical researchers with reproducible and quantitative data for a few or hundreds of proteins in a cost-effective manner. All services are performed in our CLIA certified laboratory. As a guide to drug development researchers, Myriad RBM also offers strategic biomarker services that include companion diagnostics, custom assay development, co-sponsored research programs, and innovative cell culture products. Myriad RBM's biomarker testing laboratory is a wholly owned subsidiary of Myriad Genetics, Inc. (MYGN).

keywords:N/A

$25M

Total Funding

216

Number of Employees

$41.9M

Revenue (est)

-41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Myriad RBM News

2022-04-20 - Nervous System Markers Market Segmented by Product, Application ...

Myriad RBM AbaStar MDx. QIAGEN Thermo Fisher Scientific. Region Segmentation North America (United States, Canada, Mexico) South America (Brazil, Argentina,...

2022-04-20 - Major Player in the Central Nervous System (CNS) Biomarkers ...

... While the Coronavirus Pandemic Has a Higher Impact: AbaStar MDX, Apitope International, ExonHit Therapeutics, Metabolon Inc., Myriad RBM.

2022-04-17 - Neurological Biomarkers Market Growth, Opportunity and Future ...

Myriad RBM Proteome Sciences Thermo Fisher Scientific Athena Diagnostics Immunarray Pvt. Ltd. Quanterix Corporation Diagenic ASA

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$48.7M21635%N/A
#2
$52.3M21624%N/A
#3
$34.6M217-22%N/A
#4
$59.9M21725%N/A
#5
$69.2M21732%N/A